Kota Nakamura, Zhongxu Zhu, Souvick Roy, Eunsung Jun, Haiyong Han, Ruben M Munoz, Satoshi Nishiwada, Geeta Sharma, Derek Cridebring, Frederic Zenhausern, Seungchan Kim, Denise J Roe, Sourat Darabi, In-Woong Han, Douglas B Evans, Suguru Yamada, Michael J Demeure, Carlos Becerra, Scott A Celinski, Erkut Borazanci, Susan Tsai, Yasuhiro Kodera, Joon Oh Park, John S Bolton, Xin Wang, Song Cheol Kim, Daniel Von Hoff, Ajay Goel
BACKGROUND & AIMS: Pancreatic ductal adenocarcinoma (PDAC) incidence is rising worldwide, and most patients present with an unresectable disease at initial diagnosis. Measurement of carbohydrate antigen 19-9 (CA19-9) levels lacks adequate sensitivity and specificity for early detection; hence, there is an unmet need to develop alternate molecular diagnostic biomarkers for PDAC. Emerging evidence suggests that tumor-derived exosomal cargo, particularly micro RNAs (miRNAs), offer an attractive platform for the development of cancer-specific biomarkers...
November 2022: Gastroenterology